SHANGHAI, Jan. 8, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to Class A ordinary shares from one (1) ADS representing two (2) Class A ordinary shares to the new ratio of one (1) ADS representing twenty (20) Class A or ...

111, Inc. (NASDAQ:YI) Q3 2024 Results Conference Call November 27, 2024 7:30 AM ET Company Participants Dr. Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Haihui Wang - Chief Operating Officer Conference Call Participants Jessie Lu - HSBC Robert Sassoon - Water Tower Research Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the Company are Dr. Gang Yu, Co-Fou ...

Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of 111, commented, "While the macroeconomic environment in China continues to present challenges, we are proud of our ability to maintain operational profitability for the third consecutive quarter. This achievement is a testament to the strength of our business model as a one-stop shopping platform that offers the most comprehensive selection of pharmaceutical products at competitive prices. It also highlights our commitment to operational ...

Maintained Operational Profitability for the Third Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoY Held Positive Operating Cash Flow for Three Consecutive QuartersSHANGHAI, Nov. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited fina ...

SHANGHAI, Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Friday, December 6, 2024 at 11:00 a.m. ET.Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer ...

财报发布时间调整 - 111公司原定于2024年11月28日（周四）发布截至2024年9月30日的第三季度未经审计财务业绩现调整为2024年11月27日（周三）美国市场开盘前发布 [1] 财报电话会议相关 - 111公司管理团队将于2024年11月27日（周三）美国东部时间上午7:30（北京时间当日晚上8:30）召开财报电话会议 [2] - 会议主题为111公司2024年第三季度财报电话会议注册链接为https://s1.c - conf.com/diamondpass/10042738 - te7sgd.html参与者必须提前使用该链接完成在线注册注册后将获得拨入号码密码和个人访问PIN这些信息也将以日历邀请的形式通过电子邮件发送 [2] - 请在会议开始前15分钟拨入要加入会议只需拨打日历邀请中的号码输入密码和PIN即可即时加入会议 [3] - 会议的网络直播将在https://edge.mediaserver.com/mmc/p/3nkscjv6上提供直播和存档电话重播将在会议结束后提供至2024年12月4日 [3] - 中国拨入号码为4001209216美国为+1 - 855 - 883 - 1031国际为+61 - 7 - 3107 - 6325会议ID为10042738 [3] 公司概况 - 111公司（纳斯达克股票代码:YI）是一家领先的科技赋能医疗保健平台公司致力于通过数字化赋能中国上下游重塑医疗保健行业价值链 [1][4] - 公司通过其在线零售药房1药房直接为消费者提供更好的药品和医疗保健服务并通过其线下虚拟药房网络间接提供服务 [4] - 公司还通过其互联网医院1诊所提供在线医疗保健服务为消费者提供经济高效便捷的在线咨询电子处方服务和患者管理服务 [4] - 公司的在线平台1医药是药房采购多种药品的一站式商店 [4] - 111公司拥有中国最大的虚拟药房网络使线下药房能够通过云服务更好地为客户服务还为战略合作伙伴提供全渠道药品商业化平台包括数字营销患者教育数据分析和定价监测等服务 [4] 更多信息获取 - 欲了解更多关于111公司的信息请访问http://ir.111.com.cn/ [5]

文章核心观点 - 111公司宣布董事长陈连勇博士因个人原因辞去公司董事职务,同时任命公司高级财务主管陈阳(Luke Chen)为新任董事 [1][2][3] - 公司对陈连勇博士在任期内为公司做出的重大贡献表示感谢,并期待未来继续与其合作 [2] - 公司对新任董事陈阳(Luke Chen)表示欢迎,认为其丰富的财务专业知识和对公司业务的深入理解将有助于推进公司的战略举措,为公司的持续成功和增长做出贡献 [3] 公司概况 - 111公司是一家领先的科技驱动的医疗健康平台公司,致力于通过数字化手段重塑中国医疗健康行业的价值链 [4] - 公司通过在线零售药房、互联网医院和医药供应商平台等业务,为消费者提供更好的医药产品和医疗服务获取渠道 [4] - 公司拥有中国最大的虚拟药房网络,能够帮助线下药店更好地为客户提供云端服务 [4] - 公司还为战略合作伙伴提供全渠道药品商业化平台,包括数字营销、患者教育、数据分析等服务 [4]

SHANGHAI, Oct. 22, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Wednesday, October 30, 2024 at 12:00 p.m. ET.Dr. Gang Yu, Co-Founder and Executive Chairman of 111, will dis ...

SHANGHAI, Oct. 18, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2024, before the U.S. market opens on Thursday, November 28, 2024.111's management team will host an earnings conference call at 7:30 AM U ...

SHANGHAI, Oct. 10, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that new fulfillment centers in South and Central China began operations in Guangzhou, Guangdong Province, and Wuhan, Hubei Province, respectively. These strategic expansions mark a significant step forward in enhancing its national ...